1. Home
  2. Africa

Lobby group calls for cheap AIDS drugs

As US President George W Bush visits Uganda, an international lobby group has urged the US to allow the import of generic HIV/AIDS drugs in developing countries. The US recently blocked an international World Trade Organisation (WTO) agreement to allow poor countries to buy cheap drugs. In response, Oxfam said in a statement: "By blocking negotiations that would give African countries like Botswana and Uganda access to the cheap medicines they so desperately need, the US is undermining the good of its global AIDS initiative." An estimated 80 percent of the more than 95 percent of HIV/AIDS drugs used to treat people living with HIV/AIDS (PWAs) in Uganda are imported generic versions. "If access to generic drugs in Uganda is restricted, many clinics will be forced to stop treatment of PWAs. This could mean that thousands of people who urgently need these medicines will have to go without," Oxfam added.

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Get the day’s top headlines in your inbox every morning

Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

It’s the perfect way to start your day.

Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join